Polar Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Polar Capital’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$56.4M	Buy	413,880 +311,295	+303%	+$33.1M	0.42%	71
2020 Q2	$9.91M	Buy	+102,585	New	+$8.56M	0.09%	174
2020 Q1	–	Sell	-145,000	Closed	-$10.6M	–	327
2019 Q4	$10.6M	Sell	145,000 -205,000	-59%	-$12.4M	0.09%	195
2019 Q3	$18.3M	Sell	350,000 -50,000	-13%	-$2.66M	0.16%	153
2019 Q2	$20.1M	Hold	400,000	–	–	0.18%	150
2019 Q1	$20.8M	Buy	400,000 +191,807	+92%	+$8.84M	0.19%	146
2018 Q4	$10.2M	Buy	208,193 +116,907	+128%	+$6.44M	0.11%	172
2018 Q3	$5.95M	Buy	+91,286	New	+$5.37M	0.05%	210

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Polar Capital's MYOK Position: Q3 2020 in Review

Polar Capital increased its MyoKardia, Inc. Common Stock (MYOK) stake by 303% in Q3 2020, buying an estimated $33.1M and bringing the position to 413,880 shares worth $56.4M. The position accounts for 0.42% of the portfolio, ranked #71.

Polar Capital first reported a position in MYOK in Q3 2018 and has held it in 8 quarters since. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Polar Capital held 413,880 shares of MyoKardia, Inc. Common Stock worth $56.4M as of Q3 2020.
Polar Capital bought 311,295 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $33.1M.
MyoKardia, Inc. Common Stock made up 0.42% of Polar Capital's portfolio in Q3 2020, its #71 holding.
Polar Capital first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and has held it in 8 quarters since.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.